Research Output per year
Fingerprint Dive into the research topics where Asher A Chanan Khan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 11 Similar Profiles
Multiple Myeloma
Medicine & Life Sciences
B-Cell Chronic Lymphocytic Leukemia
Medicine & Life Sciences
Therapeutics
Medicine & Life Sciences
Waldenstrom Macroglobulinemia
Medicine & Life Sciences
Thalidomide
Medicine & Life Sciences
Neoplasms
Medicine & Life Sciences
Dexamethasone
Medicine & Life Sciences
Survival
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output 2001 2019
3
Citations
(Scopus)
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2019
Wierda, W. G., Byrd, J. C., Abramson, J. S., Bilgrami, S. F., Bociek, G., Brander, D., Brown, J., Chanan Khan, A. A., Chavez, J. C., Coutre, S. E., Davis, R. S., Fletcher, C. D., Hill, B., Kahl, B. S., Kamdar, M., Kaplan, L. D., Khan, N., Kipps, T. J., Ma, S., Malek, S. & 9 others, , Jan 1 2019, In : JNCCN Journal of the National Comprehensive Cancer Network. 17, 1, p. 12-20 9 p.Research output: Contribution to journal › Article
B-Cell Chronic Lymphocytic Leukemia
Lymphoma, Large B-Cell, Diffuse
Hodgkin Disease
Lymphoma
Guidelines
IGH translocations in chronic lymphocytic leukemia: Clinicopathologic features and clinical outcomes
Fang, H., Reichard, K. K., Rabe, K. G., Hanson, C. A., Call, T. G., Ding, W. D., Kenderian, S., Muchtar, E., Schwager, S. M., Leis, J. F., Chanan Khan, A. A., Slager, S. L., Braggio, E. D., Smoley, S. A., Kay, N. E., Shanafelt, T. D., Van Dyke, D. L. & Parikh, S. A., Jan 1 2019, (Accepted/In press) In : American Journal of Hematology.Research output: Contribution to journal › Article
B-Cell Chronic Lymphocytic Leukemia
Survival
Therapeutics
Databases
1
Citation
(Scopus)
Indatuximab Ravtansine (BT062) Monotherapy in Patients With Relapsed and/or Refractory Multiple Myeloma
Jagannath, S., Heffner, L. T., Ailawadhi, S., Munshi, N. C., Zimmerman, T. M., Rosenblatt, J., Lonial, S., Chanan Khan, A. A., Ruehle, M., Rharbaoui, F., Haeder, T., Wartenberg-Demand, A. & Anderson, K. C., Jan 1 2019, In : Clinical Lymphoma, Myeloma and Leukemia.Research output: Contribution to journal › Article
Multiple Myeloma
Appointments and Schedules
Neoplasms
1
Citation
(Scopus)
Phase I study of the anti-FcRH5 antibody-drug conjugate DFRF4539A in relapsed or refractory multiple myeloma
Stewart, A. K., Krishnan, A. Y., Singhal, S., Boccia, R. V., Patel, M. R., Niesvizky, R., Chanan Khan, A. A., Ailawadhi, S., Brumm, J., Mundt, K. E., Hong, K., McBride, J., Shon-Nguyen, Q., Xiao, Y., Ramakrishnan, V., Polson, A. G., Samineni, D., Leipold, D., Humke, E. W., McClellan, J. S. & 1 others, , Feb 1 2019, In : Blood cancer journal. 9, 2, 17.Research output: Contribution to journal › Article
Open Access
Multiple Myeloma
Anti-Idiotypic Antibodies
Maximum Tolerated Dose
Antibodies
Pharmaceutical Preparations
1
Citation
(Scopus)
Prognostic risk score for patients with relapsed or refractory chronic lymphocytic leukaemia treated with targeted therapies or chemoimmunotherapy: a retrospective, pooled cohort study with external validations
Soumerai, J. D., Ni, A., Darif, M., Londhe, A., Xing, G., Mun, Y., Kay, N. E., Shanafelt, T. D., Rabe, K. G., Byrd, J. C., Chanan Khan, A. A., Furman, R. R., Hillmen, P., Jones, J., Seymour, J. F., Sharman, J. P., Ferrante, L., Mobasher, M., Stark, T., Reddy, V. & 5 others, , Jul 1 2019, In : The Lancet Haematology. 6, 7, p. e366-e374Research output: Contribution to journal › Article
B-Cell Chronic Lymphocytic Leukemia
Cohort Studies
Therapeutics
Survival
Databases